These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11389692)

  • 1. Proteasomes are a target of the anti-tumour drug vinblastine.
    Piccinini M; Tazartes O; Mezzatesta C; Ricotti E; Bedino S; Grosso F; Dianzani U; Tovo PA; Mostert M; Musso A; Rinaudo MT
    Biochem J; 2001 Jun; 356(Pt 3):835-41. PubMed ID: 11389692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human 26S proteasome is a target of antiretroviral agents.
    Piccinini M; Rinaudo MT; Chiapello N; Ricotti E; Baldovino S; Mostert M; Tovo PA
    AIDS; 2002 Mar; 16(5):693-700. PubMed ID: 11964525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex.
    Orlowski M; Wilk S
    Arch Biochem Biophys; 2000 Nov; 383(1):1-16. PubMed ID: 11097171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of 8-chloroadenosine on proteasome activity of HL-60 cells].
    Zhang Y; Wu J; Xu B; Zhang LH; Cui JR
    Ai Zheng; 2004 Feb; 23(2):155-9. PubMed ID: 14960234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
    Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
    Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of proteasomes from Trypanosoma brucei.
    Hua S; To WY; Nguyen TT; Wong ML; Wang CC
    Mol Biochem Parasitol; 1996 Jun; 78(1-2):33-46. PubMed ID: 8813675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes.
    Beyette J; Mason GG; Murray RZ; Cohen GM; Rivett AJ
    Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):315-20. PubMed ID: 9601058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EGF receptor degrades via the proteasome-dependent pathway in A-431 cells].
    Medvedeva ND; Evdonin AL; Tsupkina NV; Konstantinova IM
    Tsitologiia; 2002; 44(7):697-701. PubMed ID: 12455381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new structural class of proteasome inhibitors that prevent NF-kappa B activation.
    Lum RT; Kerwar SS; Meyer SM; Nelson MG; Schow SR; Shiffman D; Wick MM; Joly A
    Biochem Pharmacol; 1998 May; 55(9):1391-7. PubMed ID: 10076530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
    Yeung SJ; Chen SH; Chan L
    Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared.
    Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW
    Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.
    Hu Z; Zhang Z; Doo E; Coux O; Goldberg AL; Liang TJ
    J Virol; 1999 Sep; 73(9):7231-40. PubMed ID: 10438810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway.
    Cardozo C; Michaud C
    Arch Biochem Biophys; 2002 Dec; 408(1):103-10. PubMed ID: 12485608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome-dependent processing of nuclear proteins is correlated with their subnuclear localization.
    Dino Rockel T; von Mikecz A
    J Struct Biol; 2002; 140(1-3):189-99. PubMed ID: 12490167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasomes as drug targets.
    Piccinini M; Mostert M; Rinaudo MT
    Curr Drug Targets; 2003 Nov; 4(8):657-71. PubMed ID: 14577657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway.
    Xia H; Redman C
    Biochem Biophys Res Commun; 1999 Aug; 261(3):590-7. PubMed ID: 10441471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15.
    Liu M; Li XL; Hassel BA
    J Biol Chem; 2003 Jan; 278(3):1594-602. PubMed ID: 12426315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interaction of the proteasome (multicatalytic proteinase). Evidence that the proteasome is not a constituent of the '26 S' multienzyme complex.
    Seelig A; Kloetzel PM; Kuehn L; Dahlmann B
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):225-32. PubMed ID: 1741750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells.
    Gardner RC; Assinder SJ; Christie G; Mason GG; Markwell R; Wadsworth H; McLaughlin M; King R; Chabot-Fletcher MC; Breton JJ; Allsop D; Rivett AJ
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):447-54. PubMed ID: 10677365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.